1. Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study. (November 2020) Authors: Tian, Jiaxing; Yan, Shiyan; Wang, Han; Zhang, Ying; Zheng, Yujiao; Wu, Haoran; Li, Xiuyang; Gao, Zezheng; Ai, Yanke; Gou, Xiaowen; Zhang, Lei; He, Liyun; Lian, Fengmei; Liu, Baoyan; Tong, Xiaolin Journal: Pharmacological research Issue: Volume 161(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗